Suppr超能文献

大麻使用与焦虑症之间的关联:基于人群的代表性样本的研究结果。

The association between cannabis use and anxiety disorders: Results from a population-based representative sample.

作者信息

Feingold Daniel, Weiser Mark, Rehm Jürgen, Lev-Ran Shaul

机构信息

Ariel University, Israel; Addiction Medicine and Dual Diagnosis Services, Department of Psychiatry, Sheba Medical Center, Tel Hashomer, Israel.

Department of Psychiatry, Sheba Medical Center, Tel Hashomer, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

出版信息

Eur Neuropsychopharmacol. 2016 Mar;26(3):493-505. doi: 10.1016/j.euroneuro.2015.12.037. Epub 2015 Dec 29.

Abstract

The cross-sectional association between cannabis use and anxiety disorders is well documented, yet less is known about the longitudinal association between the two. This study explored the association between cannabis use, cannabis use disorders (CUDs) and anxiety disorders in a 3-year prospective study. Data was drawn from waves 1 and 2 of the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). Anxiety disorders, including generalized anxiety disorder, social anxiety, panic disorder and specific phobias, were controlled for at baseline. Initiation of cannabis use was defined as any cannabis use by former lifetime abstainers in the time period between baseline and follow-up, CUDs were defined as a diagnosis of cannabis abuse or dependence. Results indicate that cannabis use was not associated with increased incidence of any anxiety disorder (Adjusted Odds Ratio (AOR)=1.12(0.63-0.98)). Though heavy cannabis use was associated with increased incidence of social anxiety in most models, this was not fully retained in the final adjusted model (AOR=1.98(0.99-1.98)). Investigation of the association between baseline CUDs and anxiety disorders at follow-up revealed similar results. Any baseline anxiety disorder was not associated with future initiation of cannabis use (AOR=1.03(0.62-1.69)) or onset of a CUD (AOR=0.68(0.41-1.14)), yet individuals with baseline panic disorder were more prone to initiate cannabis use at follow-up (AOR=2.2(1.15-4.18)), possibly as a means of self-medication. Our findings suggest that cannabis use and CUDs are not associated with increased incidence of most anxiety disorders and inversely, most anxiety disorders are not associated with increased incidence of cannabis use or CUDs.

摘要

大麻使用与焦虑症之间的横断面关联已有充分记录,但二者之间的纵向关联却鲜为人知。本研究在一项为期3年的前瞻性研究中,探讨了大麻使用、大麻使用障碍(CUDs)与焦虑症之间的关联。数据取自全国酒精及相关疾病流行病学调查(NESARC)的第1波和第2波。在基线时对包括广泛性焦虑症、社交焦虑症、恐慌症和特定恐惧症在内的焦虑症进行了控制。大麻使用的起始定义为基线和随访期间以前终生 abstainers 的任何大麻使用,CUDs 定义为大麻滥用或依赖的诊断。结果表明,大麻使用与任何焦虑症发病率的增加无关(调整后的优势比(AOR)=1.12(0.63-0.98))。尽管在大多数模型中,大量使用大麻与社交焦虑症发病率的增加有关,但在最终调整模型中这一点并未完全保留(AOR=1.98(0.99-1.98))。对基线 CUDs 与随访时焦虑症之间关联的调查得出了类似结果。任何基线焦虑症与未来开始使用大麻(AOR=1.03(0.62-1.69))或发生 CUDs(AOR=0.68(0.41-1.14))均无关联,但基线患有恐慌症的个体在随访时更倾向于开始使用大麻(AOR=2.2(1.15-4.18)),这可能是一种自我治疗的手段。我们的研究结果表明,大麻使用和 CUDs 与大多数焦虑症发病率的增加无关,反之,大多数焦虑症与大麻使用或 CUDs 发病率的增加也无关联。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验